| 000 | 00000nam##2200000za#4500 |
| 001 | 9.699215 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210625000259 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2014||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-23532-5 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-17/2014E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 10|aUtilization of prescription opioids in Canada's public drug plans, 2006/07 to 2012/13 |h[electronic resource] |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |cApril 2014. |
|---|
| 300 | |a62p.|bfigs., graphs, tables |
|---|
| 590 | |a14-44|b2014-10-31 |
|---|
| 690 | 07|aPrescription drugs|2gcpds |
|---|
| 775 | 08|tL'utilisation d'opioïdes sur ordonnance dans les régimes publics d'assurance-médicaments du Canada, de 2006-2007 à 2012-2013 |w(CaOODSP)9.643169 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s3.02 MB|uhttps://publications.gc.ca/collections/collection_2014/cepmb-pmprb/H82-17-2014-eng.pdf |
|---|